<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"adipophilin":1,
"apocrine-like features":1,
"lipogenic pathway":1,
"lung adenocarcinoma":1,
"prognosis":6,
"Epigenetics":3,
"Medullary thyroid carcinoma":5,
"MicroRNA":3,
"Noncoding RNA":1,
"RET":4,
"central neck dissection":1,
"occult lymph node metastasis":1,
"papillary thyroid carcinoma":20,
"prophylactic neck dissection":1,
"Anaplastic thyroid carcinoma":2,
"Non-coding RNA":1,
"Poorly differentiated thyroid carcinoma":2,
"Cabeça e pescoço":1,
"Free flaps":1,
"Head and neck":3,
"Outcomes":1,
"Reconstruction":1,
"Reconstrução":1,
"Resultados":1,
"Retalhos livres":1,
"Epigenetic drugs":1,
"Epigenetic writers":1,
"Histone deacetylase and acetyl transferase":1,
"Thyroid cancer cells":1,
"erasers and readers":1,
"Antitiroglobulina elevada":1,
"Chronic lymphocytic thyroiditis":1,
"Câncer de tireoide":1,
"Doença persistente e recorrente":1,
"Elevated antithyroglobulin":1,
"Persistent and recurrent disease":1,
"Thyroid cancer":19,
"Tireoidite linfocítica crônica":1,
"Biomarkers":3,
"Follicular thyroid carcinoma":2,
"Thyroid tumors":1,
"Diagnosis":4,
"LncRNAs":1,
"Metabolic syndrome":1,
"Prevalence":1,
"Ultrasonography":7,
"Thyroid nodule":9,
"Isthmusectomy":1,
"Thyroid isthmus":1,
"Total thyroidectomy":1,
"Iodine":2,
"Iodolipid":1,
"ROS":3,
"Thyroid":18,
"Anaplastic thyroid cancer":3,
"Benign thyroid disease":1,
"Familial non-medullary thyroid cancer":1,
"Papillary thyroid cancer":4,
"Penetrance":1,
"Risk":1,
"NOX4":1,
"Selenium":1,
"TGF-β":1,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"Thyroid neoplasms":4,
"Differentiated thyroid cancer":5,
"Efficacy":1,
"Meta-analysis":3,
"Pulmonary metastasis":1,
"Radioiodine therapy":1,
"BRAF":2,
"MassARRAY":1,
"NTRK1":1,
"TERT":2,
"Aspirin":1,
"Circulating tumor cells":1,
"Epithelial–mesenchymal transformation":1,
"Vimentin":1,
"Endoscopic":1,
"Thyroid surgery":2,
"Transoral":2,
"adequacy":1,
"fine-needle aspiration biopsy":1,
"thyroid/parathyroid":2,
"3-dimensional":1,
"elastography":2,
"shear wave elastography":1,
"ultrasound":4,
"Adrenal insufficiency":2,
"Autoimmune hypophysitis":1,
"Immune checkpoint inhibitors":2,
"Immune related adverse events":1,
"Thyroiditis":1,
"cytology":3,
"diagnostic accuracy":2,
"HGF/Met":1,
"TR4":1,
"metastasis":1,
"nuclear receptor":1,
"renal cell carcinoma":1,
"TI-RADS":2,
"biopsy":4,
"quality assurance":1,
"standardization":1,
"thyroid nodules":5,
"EGFR inhibitors":1,
"Rash":1,
"Rash management":1,
"Treatment costs":1,
"Treatment persistence":1,
"Radioactive remnant ablation":1,
"TSH stimulation":1,
"Big data":1,
"Cancer management":1,
"Data pooling":1,
"Personalized medicine":1,
"Radiotherapy":2,
"European reference networks joint action of rare cancers":1,
"Head and neck cancer":1,
"Multidisciplinary team":1,
"Rare disease":1,
"eosinophilia":1,
"fine-needle aspiration":4,
"sclerosing mucoepidermoid carcinoma":1,
"Aggregation assays":1,
"CGRP family":1,
"Type 2 diabetes":1,
"αCGRP":1,
"‘Aggregation-prone’ peptide":1,
"aggressive variant":1,
"solid":1,
"solid variant":1,
"solid/trabecular":1,
"trabecular":1,
"incidental thyroid nodules":1,
"thyroid incidentalomas":1,
"OCT4":1,
"SOX2":1,
"Triple-negative breast cancer":2,
"Tumor tissue":1,
"consumptive hypothyroidism":2,
"Hemangioma":1,
"type 3 iodothyronine deiodinase, propranolol":1,
"Chemical oxygen demand":1,
"Geographically weighted regression":1,
"Industrial density":1,
"Spatial scan statistics":1,
"ATC":1,
"PTCSC3":1,
"STAT3":2,
"doxorubicin":2,
"drug resistance":1,
"Multiple correspondence analysis":1,
"Prospective observational trial":1,
"DPP-4 inhibitors":1,
"site-specific cancer":1,
"systematic literature review":1,
"cell proliferation and cytokinesis":1,
"filament formation":1,
"nervous and reproductive systems":1,
"septin7":1,
"epidemiology":1,
"incidence":2,
"pediatric head and neck cancer":1,
"Desmoplastic reaction":1,
"Fibrosis":1,
"Myofibroblast":1,
"Pancreatic ductal adenocarcinoma":1,
"carcinosarcoma":2,
"pilomatricoma":1,
"pilomatrix carcinoma":1,
"pilomatrix carcinosarcoma":1,
"sarcomatoid pilomatrix carcinoma":1,
"CNS tumors":1,
"neuro-oncology":1,
"pediatric hematology/oncology":1,
"radiation oncology":1,
"radiation therapy":1,
"ALK":1,
"Chernobyl":2,
"ionising radiation":1,
"Afirma gene expression classifier (GEC)":1,
"ThyroSeq":1,
"molecular":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Frozen autograft":1,
"Recapping laminoplasty":1,
"Tenosynovial giant cell tumor":1,
"Thoracic spine":1,
"fucose":1,
"glycosylation":1,
"lectin":1,
"sialic acid":1,
"thyroid carcinoma":3,
"ATA risk stratification":1,
"disease-free survival":1,
"dynamic risk stratification":1,
"proportion of variance explained":1,
"structural recurrence":1,
"thyroid lobectomy":1,
"Cell senescence":1,
"NF-κB":2,
"Punicalagin":1,
"Senescence-associated secretory phenotype (SASP)":1,
"Carcinoma extension":1,
"Lymph node metastasis":2,
"Papillary carcinoma":1,
"Tumor-node-metastasis staging system":1,
"cancer":5,
"circadian rhythm disruption":1,
"cohort studies":1,
"cosmic ionizing radiation":1,
"exposure response":1,
"flight attendants":1,
"Bilateral breast approach":1,
"Operating bed adjustment":1,
"Skin traction point":1,
"Standardization of simple auxiliary method":1,
"Thyroid retractor point":1,
"Total endoscopic thyroidectomy":1,
"copy number gain":1,
"follicular thyroid tumour":1,
"hypermethylation":1,
"mutation":1,
"Cyclic fluctuation of serum TSH levels":1,
"TSH-secreting pituitary adenoma":1,
"interobserver agreement":1,
"interobserver variability":1,
"thyroid malignancy":1,
"thyroid ultrasound":1,
"Chinese population":1,
"POLR2E":1,
"rs3787016":1,
"Radioiodine":2,
"CyclinD1":1,
"Gefitinib":1,
"PKM2":1,
"Shikonin":1,
"Thyroid gland":3,
"adolescents and young adults (AYAs)":1,
"cancer survivors":1,
"conditional survival":1,
"relative survival":1,
"dabrafenib":2,
"pembrolizumab":1,
"sarcomatoid":1,
"squamous":1,
"trametinib":2,
"undifferentiated":2,
"aspiration":1,
"capillary action":1,
"needle gauge":1,
"non-diagnostic rate":1,
"thyroid fine-needle biopsy":1,
"ablation":1,
"extrathyroidal extension":1,
"low-dose":1,
"lymph node metastases":1,
"radioactive iodine":1,
"(18)F-DOPA":1,
"Carcinoma medular de tiroides":1,
"Cirugía radioguiada":1,
"Metastasectomy":1,
"Metastasectomía":1,
"Radioguided surgery":1,
"Power Doppler ultrasound":1,
"contrast-enhancement ultrasound":1,
"quantitative imaging":1,
"tumor vascularity":1,
"I-131 remmnant ablation":1,
"Low dose of I-131":1,
"Low-iodine diet":1,
"Urinary iodine":1,
"complications":1,
"lingual thyroid":1,
"miscellaneous":1,
"surgical outcomes":1,
"VWD":1,
"VWF":1,
"diabetes":2,
"elderly":1,
"Adipose tissue":1,
"Breast cancer":4,
"Monocarboxylate transporters":1,
"incidental cancer":1,
"incidental detection":1,
"overdiagnosis":1,
"thyroid cancer incidence":1,
"Central lymph node metastasis":1,
"Microcarcinoma":1,
"Nomogram":1,
"metformin":1,
"population-based study":1,
"protective effect":1,
"TSH receptor":1,
"inverse agonist":1,
"monoclonal antibody":1,
"bone marrow dosimetry":1,
"remnant tissue dosimetry":1,
"thyroid ablation treatment":1,
"lymphocytic thyroiditis":1,
"radioiodine ablation":1,
"thyroglobulin":3,
"thyroglobulin antibodies":1,
"Brain metastasis":1,
"Skull metastasis":2,
"Surgery":2,
"Viscum album":1,
"mistletoe":1,
"rectal cancer":1,
"Microvascular free flap":1,
"Oral cancer":1,
"Squamous cell carcinoma":1,
"UW-QoL v4":1,
"oral reconstruction":1,
"Liquid-based cytology":1,
"Hyalinizing trabecular tumor":1,
"focal adhesion kinase/extracellular signal-regulated kinase":1,
"human epidermal growth factor receptor 2":1,
"microRNA-150":1,
"mucin 4":1,
"copy-number variation":1,
"genome-wide linkage analysis":1,
"multinodular goiter":1,
"next-generation sequencing":1,
"SEER database":1,
"Salivary gland malignancy":1,
"Second primary malignancy":1,
"X-Ray":1,
"Computed Tomography":2,
"Frontal Sinus":1,
"Inverted Papilloma":1,
"Magnetic Resonance Imaging":1,
"Paranasal Sinus Diseases":1,
"Angiosarcoma":1,
"Chemotherapy":1,
"Sarcoma":1,
"Therapy":1,
"Treatment":1,
"Cbp/p300-interacting transactivator with glutamic acid and aspartic acid rich C-terminal domain 1":1,
"gene":1,
"anticancer perspectives":1,
"hydroxytyrosol":1,
"metabolism":1,
"oleuropein":1,
"olive oil phenols":1,
"Molecular pathology":1,
"Oncogene addiction":1,
"Somatic mutation":1,
"Thyroid tumor":1,
"infantile hepatic haemangioma":1,
"type 3 iodothyronine deiodinase":1,
"distant metastasis":1,
"pediatric thyroid cancer":1,
"pre-ablation stimulated thyroglobulin":1,
"Fluorodeoxyglucose":1,
"positron emission tomography-computed tomography":1,
"radioiodine scan":1,
"thyroglobulin nonsecretor":1,
"68Ga-DOTANOC":1,
"68Ga-prostate-specific membrane antigen":1,
"positron emission tomography/computed tomography":1,
"Guideline":2,
"Recommendation":1,
"RF ablation":1,
"Radiofrequency ablation":1,
"Thyroid recurrent cancers":1,
"Biopsy technique":1,
"Core needle biopsy (CNB)":1,
"Fine-needle aspiration (FNA)":1,
"Follicular-patterned lesion":1,
"Artificial intelligence":1,
"Computer-aided diagnosis":1,
"Echogenicity":1,
"Histopathology":1,
"Large-core needle":1,
"Computer-aided unsupervised clustering method":1,
"Gastric cancer":1,
"Tumor-node-metastasis staging":1,
"Molecular testing":1,
"Pathology":3,
"Pleomorphism":1,
"Gonadal hormone":1,
"Obesity":1,
"Radioactive iodide therapy":1,
"Sodium iodide symporter":1,
"Thyroid hormone":1,
"Thyroid hormone receptor":2,
"carcinoma, papillary":1,
"cysts":1,
"neck":1,
"thyroglossal cyst":1,
"endoscopy":2,
"mental nerve":1,
"thyroidectomy":1,
"131I thyroid dose":1,
"age-matched groups":1,
"radiation":2,
"atherosclerosis":1,
"coronary artery bypass grafting":1,
"low-density lipoprotein cholesterol":1,
"proprotein convertase subtilisin/kexin type 9 (pcsk9)":1,
"saphenous vein grafts disease":1,
"Carcinoid tumor":1,
"Immunohistochemistry":4,
"Ovarian neoplasms":1,
"Thyroid diseases":1,
"Immunotherapy":1,
"Lenvatinib":1,
"Salvage":1,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"indolent behavior":1,
"noninvasive follicular thyroid tumor with papillary-like nuclear features":1,
"revised nomenclature":1,
"Autotransplanted thyroid":1,
"thyroid metastasis":1,
"thyroid neoplasm":1,
"digital pathology":1,
"tall-cell variant":1,
"AKT":1,
"Activation":1,
"Expression":1,
"Isoform":1,
"Phosphorylation":1,
"RPPA":1,
"Anti-programmed cell death-1":1,
"Hepatocellular carcinoma":2,
"Immune-related adverse event":1,
"Sick sinus syndrome":1,
"Central diabetes insipidus":1,
"Cerebral salt wasting syndrome":1,
"Hyponatremia":1,
"Pituitary":1,
"MEK (mitogen-activated protein kinase kinase) inhibitor":1,
"miRNAs":1,
"radioiodine refractory differentiated thyroid cancer":1,
"Denmark":1,
"incidental findings":1,
"iodine deficiency":1,
"neoplasms":2,
"positron emission tomography":2,
"Anaplastic thyroid cancer (ATC)":1,
"Apoptosis":1,
"Green fluorescent protein (GFP)":1,
"Newcastle disease virus (NDV)":1,
"p38 MAPK":1,
"unknown primary tumor":1,
"Industry":1,
"Women, Working":1,
"multidrug resistance":1,
"nanostructured lipid carriers":1,
"β-lapachone":1,
"I-131":1,
"fluid":1,
"whole body retention":1,
"N-nitroso compounds":1,
"adverse reproductive outcomes":1,
"drinking water":1,
"endogenous nitrosation":1,
"methemoglobinemia":1,
"nitrate":1,
"thyroid disease":1,
"Breast reconstruction":1,
"Core needle biopsy":1,
"Oncoplastic breast surgery":1,
"Phyllodes tumor":1,
"NASH":1,
"T2":1,
"T3":1,
"liver cell proliferation":1,
"regenerative medicine":1,
"thyromimetics":1,
"SPINA-GT":1,
"TSH index":1,
"calcification":1,
"coronary artery calcification":1,
"thyroid hormones":1,
"carcinoma":2,
"fine needle aspiration (FNA)":1,
"indeterminate":1,
"nodule":1,
"Age":1,
"Disparity":1,
"adrenal disorders":1,
"metabolic disorders":1,
"Malignant struma ovarii":1,
"Oopherectomy":1,
"Salipingo-oopherectomy":1,
"Total abdominal hysterectomy":1,
"Carcinogenesis":1,
"DNA methylation":1,
"Epigenomics":1,
"Infection":1,
"L56M":1,
"MEN2":1,
"pheochromocytoma":1,
"Asymptomatic":1,
"Hashimoto's thyroiditis":1,
"female preponderance":1,
"subclinical hypothyroid":1,
"Biphasic tumor":1,
"DICER1 mutation":1,
"Lung metastasis":1,
"RET mutation":1,
"calcitonin":2,
"multiple endocrine neoplasia type 2":1,
"PTC, RAS":1,
"point mutation":1,
"struma ovarii":1,
"cerebriform nuclei":1,
"colloid inclusion":1,
"marginal vacuoles":1,
"nuclear grooves":1,
"Coexistence":1,
"primary thyroid lymphoma":2,
"Anesthesia":1,
"lung mass":1,
"mucoepidermoid":1,
"Cell proliferation":1,
"SOS1":1,
"microRNA-4728 (miR-4728)":1,
"HIF inhibitors":1,
"Metastatic Pheochromocytoma":1,
"Metastatic paraganglioma":1,
"tyrosine kinase inhibitors":1,
"NGAL":1,
"chemokines":1,
"chemotaxis":1,
"Diffuse B-cell lymphoma":1,
"BRAF V600E":1,
"RAS mutations":1,
"Esophageal carcinoma":1,
"small cell carcinoma":1,
"CT":1,
"Dose reduction":1,
"Cytokeratin7":1,
"breastadenocarcinoma":1,
"cervicalcancer":1,
"F-18 fluorodeoxyglucose":1,
"incidentaloma":1,
"maximum standardized uptake value":1,
"positron emission tomography computed tomography":1,
"Carcinoma thyroid":1,
"poorly differentiated":1,
"RNA editing":1,
"alternative splicing":1,
"circular RNAs":1,
"drug susceptibility":1,
"long non-coding RNAs":1,
"hyperthyroidism":1,
"Differentiation markers":1,
"Sensitivity and Specificity":1,
"Transcription factors":1,
"Tumor markers":1,
"Adrenocortical carcinoma":1,
"liver":1,
"(100 2960) Image analysis":1,
"(170 6935) Tissue characterization":1,
"(180 4315) Nonlinear microscopy":1,
"Strain Elastography":1,
"minimally invasive surgery":1,
"robot-assisted transaxillary thyroidectomy":1,
"CTCs":1,
"Endocrine system diseases":1,
"cfDNA":1,
"ER-stress":1,
"TrxR1":1,
"alantolactone":1,
"gastric metastasis":1,
"FOXD2-AS1":1,
"Therapeutic target":1,
"lncRNA":1,
"neuroimaging":1,
"pituitary disorders":1,
"Fluorescence in-situ hybridization":1,
"Hürthle cell":1,
"CTLA-4":1,
"PD-1":1,
"PD-L1":1,
"hypophysitis":1,
"thyroid disorders":1,
"fluorodeoxyglucose F18":1,
"lymph node":1,
"cervical metastases":1,
"chronic diarrhea":1,
"metastatic medullary thyroid carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
